Ado-trastuzumab emtansine Interactions
There are 296 drugs known to interact with ado-trastuzumab emtansine, along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 56 are major, and 240 are moderate.
- View all 296 medications that may interact with ado-trastuzumab emtansine
- View ado-trastuzumab emtansine alcohol/food interactions (1)
- View ado-trastuzumab emtansine disease interactions (5)
Most frequently checked interactions
View interaction reports for ado-trastuzumab emtansine and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Acephen (acetaminophen)
- Adriamycin (doxorubicin)
- Advil Liqui-Gels (ibuprofen)
- Aleve (naproxen)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Azo-Cranberry (cranberry)
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- Briumvi (ublituximab)
- Caltrate 600+D (calcium / vitamin d)
- Cequa (cyclosporine ophthalmic)
- Cheratussin AC (codeine / guaifenesin)
- Claritin 24 Hour Allergy (loratadine)
- Claritin-D (loratadine / pseudoephedrine)
- CVS Gas Relief (simethicone)
- Diphen (diphenhydramine)
- Ditropan XL (oxybutynin)
- Eligen B12 (cyanocobalamin)
- Emend (aprepitant)
- Estrace (estradiol)
- Iron Sulfate (ferrous sulfate)
- MiraLAX (polyethylene glycol 3350)
- Pepto-Bismol (bismuth subsalicylate)
- Tums Extra Strength 750 (calcium carbonate)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zantac (ranitidine)
Ado-trastuzumab emtansine alcohol/food interactions
There is 1 alcohol/food interaction with ado-trastuzumab emtansine.
Ado-trastuzumab emtansine disease interactions
There are 5 disease interactions with ado-trastuzumab emtansine which include:
Report options
More about ado-trastuzumab emtansine
- ado-trastuzumab emtansine consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.